3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
43
Colorectal Neoplasms
15
Squamous Cell Carcinoma of Head and Neck
13
Lung Neoplasms
13
Carcinoma, Non-Small-Cell Lung
13
Melanoma
12
Head and Neck Neoplasms
12
Pancreatic Neoplasms
11
Colonic Neoplasms
11
Carcinoma, Renal Cell
11
Rectal Neoplasms
10
Prostatic Neoplasms
9
Carcinoma, Ovarian Epithelial
8
Ovarian Neoplasms
7
Esophageal Neoplasms
7
Breast Neoplasms, Male
7
Salivary Gland Neoplasms
6
Lymphoma, Follicular
6
Lymphoma, B-Cell, Marginal Zone
6
Liver Neoplasms
6
Stomach Neoplasms
5
Precancerous Conditions
5
Lymphoma, Mantle-Cell
5
Lymphoma, Large-Cell, Anaplastic
5
Lymphoma, Large B-Cell, Diffuse
5
Kidney Neoplasms
5
Esophageal Squamous Cell Carcinoma
5
Breast Carcinoma In Situ
5
Adenocarcinoma Of Esophagus
5
Uterine Cervical Neoplasms
4
Interventions
Blood Specimen Collection
2
poly ICLC
1
Vinorelbine
1
Therapeutics
1
Reverse Transcriptase Polymerase Chain Reaction
1
Probiotics
1
Poly I-C
1
Pemetrexed
1
Paclitaxel
1
Monatide (IMS 3015)
1
Immunohistochemistry
1
Docetaxel
1
Cosmetics
1
Cisplatin
1
Carboplatin
1
Bronchoalveolar Lavage
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Carcinogenesis
×
Immunohistochemistry
×
Clear all
NCT06778538
2025-01-16
HPGD-ccRCC
Lanzhou University Second Hospital
Completed
40 enrolled